Abstract: This disclosure provides methods of using compositions comprising amino acid entities to reduce fat infiltration in muscle, particularly under conditions of muscle atrophy. The disclosure also provides methods for enhancing muscle function by reducing fat infiltration in the muscle comprising administering an effective amount of the compositions to a subject in need thereof.
Type:
Grant
Filed:
March 2, 2021
Date of Patent:
December 5, 2023
Assignee:
AXCELLA HEALTH INC.
Inventors:
Manu Chakravarthy, William Comb, Michael Hamill, Anthony Tramontin
Abstract: This disclosure provides pharmaceutical compositions comprising amino acid entities and uses thereof. Methods for treating post-acute sequelae of COVID-19 comprising administering an effective amount of the compositions to a subject in need thereof are also disclosed.
Type:
Grant
Filed:
July 25, 2022
Date of Patent:
August 29, 2023
Assignee:
AXCELLA HEALTH INC.
Inventors:
Revati Wani, Alison Schecter, Michael Hamill, Margaret Koziel, Matthew Russell, Karim Azer, Karen Lavery, Joel Pradines
Abstract: This disclosure provides methods of manufacturing large-scale blended preparations comprising one or more amino acids wherein the preparations have certain properties.
Type:
Grant
Filed:
June 19, 2019
Date of Patent:
June 20, 2023
Assignee:
AXCELLA HEALTH INC.
Inventors:
Thomas Hanlon, Ralph Yamamoto, Denise K. Kwok, Daniel Rothenberg, Andrew M. Wood
Abstract: This disclosure provides pharmaceutical compositions comprising defined amino acid components, and methods for treating traumatic brain injury comprising administering an effective amount of the compositions to a subject in need thereof.
Type:
Grant
Filed:
April 27, 2018
Date of Patent:
April 4, 2023
Assignee:
AXCELLA HEALTH, INC.
Inventors:
Sean Carroll, Raffi Afeyan, Gianluca De Rienzo, Matthew Russell
Abstract: This disclosure provides pharmaceutical compositions comprising amino acid entities and uses thereof. Methods for improving liver function and for treating liver diseases comprising administering an effective amount of the compositions to a subject in need thereof are also disclosed.
Type:
Grant
Filed:
July 1, 2020
Date of Patent:
March 14, 2023
Assignee:
AXCELLA HEALTH INC.
Inventors:
Michael Hamill, Raffi Afeyan, Chung-Wei Lee, Harry Luithardt
Abstract: This disclosure provides compositions and methods for treating or preventing liver diseases and disorders with hyperammonemia or muscle wasting in a subject.
Type:
Grant
Filed:
April 15, 2020
Date of Patent:
February 7, 2023
Assignee:
AXCELLA HEALTH INC.
Inventors:
William Comb, Sean Carroll, Raffi Afeyan, Michael Hamill
Abstract: Nutritive polypeptides are provided herein. Also provided are various other embodiments including nucleic acids encoding the polypeptides, recombinant microorganisms that make the polypeptides, vectors for expressing the polypeptides, methods of making the polypeptides using recombinant microorganisms, compositions and formulations that comprise the polypeptides, and methods of using the polypeptides, compositions and formulations.
Type:
Grant
Filed:
March 16, 2020
Date of Patent:
June 14, 2022
Assignee:
Axcella Health Inc.
Inventors:
Michael Hamill, Brett Boghigian, Caitlyn Harvey, David Berry, David Young, Geoffrey Von Maltzahn, John Kramarczyk, Jameson Rogers, Kathryn Heard, Michael Doherty, Nathaniel Silver, Phillip Samayoa, Subhayu Basu, Shaila Rahman, Vimal Vaidya, Ying-Ja Chen
Abstract: This disclosure provides pharmaceutical compositions comprising amino acid entities and uses thereof. Methods for improving liver function and for treating liver diseases comprising administering an effective amount of the compositions to a subject in need thereof are also disclosed.
Type:
Grant
Filed:
December 19, 2017
Date of Patent:
September 28, 2021
Assignee:
AXCELLA HEALTH INC.
Inventors:
Michael Hamill, Raffi Afeyan, Chung-Wei Lee, Harry Luithardt, David Berry
Abstract: This disclosure provides pharmaceutical compositions comprising amino acid entities and uses thereof. Methods for improving liver function and for treating liver diseases comprising administering an effective amount of the compositions to a subject in need thereof are also disclosed.
Type:
Grant
Filed:
December 19, 2017
Date of Patent:
August 24, 2021
Assignee:
AXCELLA HEALTH INC.
Inventors:
Michael Hamill, Raffi Afeyan, Chung-Wei Lee, Harry Luithardt, David Berry
Abstract: This disclosure provides compositions and methods for improving erythrocyte dysfunction or treating a hemoglobinopathy or a thalassemia (e.g., sickle cell disease or ?-thalassemia).
Type:
Grant
Filed:
June 19, 2019
Date of Patent:
July 13, 2021
Assignee:
AXCELLA HEALTH INC.
Inventors:
Sean Carroll, Matthew Russell, Raffi Afeyan
Abstract: This disclosure provides methods of using compositions comprising amino acid entities to reduce fat infiltration in muscle, particularly under conditions of muscle atrophy. The disclosure also provides methods for enhancing muscle function by reducing fat infiltration in the muscle comprising administering an effective amount of the compositions to a subject in need thereof.
Type:
Grant
Filed:
February 7, 2020
Date of Patent:
April 13, 2021
Assignee:
AXCELLA HEALTH INC.
Inventors:
William Comb, Michael Hamill, Raffi Afeyan
Abstract: This disclosure provides compositions and methods for treating or preventing liver diseases and disorders with hyperammonemia or muscle wasting in a subject.
Type:
Grant
Filed:
August 14, 2018
Date of Patent:
June 16, 2020
Assignee:
AXCELLA HEALTH INC.
Inventors:
William Comb, Sean Carroll, Raffi Afeyan, Michael Hamill
Abstract: This disclosure provides compositions and methods for treating or preventing liver diseases and disorders with hyperammonemia or muscle wasting in a subject.
Type:
Grant
Filed:
April 29, 2019
Date of Patent:
May 26, 2020
Assignee:
AXCELLA HEALTH INC.
Inventors:
William Comb, Sean Carroll, Raffi Afeyan, Michael Hamill
Abstract: This disclosure provides methods of using compositions comprising amino acid entities to reduce fat infiltration in muscle, particularly under conditions of muscle atrophy. The disclosure also provides methods for enhancing muscle function by reducing fat infiltration in the muscle comprising administering an effective amount of the compositions to a subject in need thereof.
Type:
Grant
Filed:
June 19, 2019
Date of Patent:
March 24, 2020
Assignee:
AXCELLA HEALTH INC.
Inventors:
Manu Chakravarthy, William Comb, Michael Hamill, Tony Tramontin
Abstract: This disclosure provides pharmaceutical compositions comprising amino acid entities and uses thereof. Methods for improving liver function and for treating liver diseases comprising administering an effective amount of the compositions to a subject in need thereof are also disclosed.
Type:
Grant
Filed:
December 5, 2018
Date of Patent:
November 12, 2019
Assignee:
AXCELLA HEALTH INC.
Inventors:
Michael Hamill, Raffi Afeyan, Chung-Wei Lee, Harry Luithardt
Abstract: Nutritive polypeptides are provided herein. Also provided are various other embodiments including nucleic acids encoding the polypeptides, recombinant microorganisms that make the polypeptides, vectors for expressing the polypeptides, methods of making the polypeptides using recombinant microorganisms, compositions and formulations that comprise the polypeptides, and methods of using the polypeptides, compositions and formulations.
Type:
Grant
Filed:
March 25, 2016
Date of Patent:
November 5, 2019
Assignee:
Axcella Health Inc.
Inventors:
Michael Hamill, Brett Boghigian, Caitlyn Harvey, David Berry, David Young, Geoffrey Von Maltzahn, John Kramarczyk, Jameson Rogers, Kathryn Heard, Michael Doherty, Nathaniel Silver, Phillip Samayoa, Subhayu Basu, Shaila Rahman, Vimal Vaidya, Ying-Ja Chen
Abstract: Charged nutritive proteins are provided. In some embodiments the nutritive proteins an aqueous solubility of at least 12.5 g/L at pH 7. In some embodiments the nutritive proteins an aqueous solubility of at least 50 g/L at pH 7. In some embodiments the nutritive proteins an aqueous solubility of at least 100 g/L at pH 7.
Type:
Grant
Filed:
February 10, 2017
Date of Patent:
October 22, 2019
Assignee:
Axcella Health Inc.
Inventors:
David Arthur Berry, Brett Adam Boghigian, Nathaniel W. Silver, Geoffrey von Maltzahn, Michael Hamill, Rajeev Chillakuru, John F. Kramarczyk
Abstract: This disclosure provides pharmaceutical compositions comprising amino acid entities and uses thereof. Methods for improving liver function and for treating liver diseases comprising administering an effective amount of the compositions to a subject in need thereof are also disclosed.
Type:
Grant
Filed:
December 29, 2017
Date of Patent:
March 26, 2019
Assignee:
AXCELLA HEALTH INC.
Inventors:
Michael Hamill, Raffi Afeyan, Chung-Wei Lee, Harry Luithardt, David Berry
Abstract: This disclosure provides pharmaceutical compositions comprising amino acid entities and uses thereof. Methods for improving liver function and for treating liver diseases comprising administering an effective amount of the compositions to a subject in need thereof are also disclosed.